TITLE

TB Progress

PUB. DATE
June 2010
SOURCE
Pharmaceutical Representative;Jun2010, Vol. 40 Issue 6, p9
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the progress of research and development for treatments of tuberculosis (TB).
ACCESSION #
51363069

 

Related Articles

  • Determining quantitative targets for public funding of tuberculosis research and development. Walwyn, David R. // Health Research Policy & Systems;2013, Vol. 11 Issue 1, p1 

    South Africa's expenditure on tuberculosis (TB) research and development (R&D) is insignificant relative to both its disease burden and the expenditure of some comparator countries with a minimal TB incidence. In 2010, the country had the second highest TB incidence rate in the world (796 per...

  • Development of structurally diverse antitubercular molecules with pyridazine ring. Asif, Mohammad; Singh, Anita; Lakshmayya // Chronicles of Young Scientists;Jan-Jun2013, Vol. 4 Issue 1, p1 

    There has been considerable interest in the development of new molecule with antibacterial activities particularly against tuberculosis because mycobacterium species have developed resistance against currently used drugs, their toxic effect, and longer duration of therapy. The pyridazine...

  • Drugs to tackle tropical diseases are the need of the hour. Thomas, Zakir // BioSpectrum;Feb2013, Vol. 11 Issue 2, p70 

    The article focuses on the most common diseases that affect the Indian population and its need for attention from the government and public policy. It mentions several diseases that raise such concerns such as tuberculosis (TB), malaria, and leishmaniasis. It tackles other problems associated...

  • Biotechs, Pharmas, Nonprofits Partner in New R&D Model. Powers, Marie // BioWorld Today;6/25/2012, Vol. 23 Issue 122, p2 

    The article focuses on the World Intellectual Property Organization (WIPO) Re:Search, a multilateral voluntary consortium that aims to facilitate research and development partnerships to repurpose Intellectual Property (IP). It is building a searchable, public database of IP on pharmaceutical...

  • Evaluation and determinats of outcome of tuberculosis treatment. Maher, D.; Nunn, P. // Bulletin of the World Health Organization;1998, Vol. 76 Issue 3, p307 

    Presents information on the evaluated outcome of tuberculosis (TB) treatment. What accurate evaluation of treatment outcomes requires; Necessity of innovative approaches; Information on the national tuberculosis programme (NTP).

  • Tuberculosis. Zamula, E. // FDA Consumer;Mar1991, Vol. 25 Issue 2, p18 

    Examines how tuberculosis, once a top killer has declined dramatically in the first half of this century thanks to new drug treatments, improved hygiene, and better understanding of the disease. But now, the number of TB cases is beginning to creep up again. Airborne transmission; Testing for...

  • Supervised therapy cuts drug resistance, relapse in TB patients.  // Modern Medicine;Nov94, Vol. 62 Issue 11, p73 

    Presents an abstract of an article entitled `The Effect of Directly Observed Therapy on the Rates of Drug Resistance and Relapse in Tuberculosis,' by S.E. Weis, P.C. Slocum, F.X. Blais, et al. on the April 28, 1994 issue of the `New England Journal of Medicine.'

  • NIAID mounts nationwide HIV-TB treatment study. Folkers, Greg // Public Health Reports;Jul/Aug93, Vol. 108 Issue 4, p520 

    Informs that the National Institute of Allergy and Infectious Diseases (NIAID) has launched the first large US study to assess tuberculosis treatment strategies for persons infected with both tuberculosis and the HIV virus. The AIDS Clinical Trial Group; The Terry Beirn Community Programs for...

  • Implications of directly observed therapy in tuberculosis control measures among IDUs. Curtis, Richard; Friedman, Samuel R. // Public Health Reports;May/Jun94, Vol. 109 Issue 3, p319 

    Offers a review of the responses of intravenous drug users (IDU) to current tuberculosis (TB) control strategies. Discussion of the implications of the findings for the proposed implementation of directly observed therapy (DOT); View that current TB diagnosis and treatment systems are, at best,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics